Science Daily: Pharmacology News

APRIL 29, 2024

The first study of the use of microarray patches to vaccinate children has shown that the method is safe and induces strong immune responses.

Vaccine 310

Vaccine Trials Immune Response 310

Science Daily: Pharmacology News

MAY 17, 2024

An HIV vaccine candidate triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.

Vaccine 337

Vaccine Trials Clinical Trials 337

Science Daily: Pharmacology News

AUGUST 22, 2024

A new flu vaccine candidate incorporates proteins from 8 strains of influenza.

Vaccine 300

Vaccine 300

Science Daily: Pharmacology News

JANUARY 21, 2025

Antibiotics, antivirals, vaccinations and anti-inflammatory medication are associated with reduced risk of dementia, according to new research that looked at health data from over 130 million individuals.

Vaccine 319

Vaccine Research 319

Science Daily: Pharmacology News

DECEMBER 11, 2024

Scientists' findings in mice could translate into a radical, needle-free vaccination approach that would also eliminate reactions including fever, swelling and pain.

Vaccine 294

Vaccine 294

Science Daily: Pharmacology News

MAY 29, 2024

Review of research to-date suggests vaccination remains the most effective strategy for avian influenza prevention and control in humans, despite varying vaccine efficacy across strains.

Vaccine 295

Vaccine Research 295

Science Daily: Pharmacology News

MARCH 27, 2024

Those with aging immune systems struggle to fight off novel viruses and respond weakly to vaccination. Researchers were able to revitalize the immune system in mice.

Vaccine 312

Vaccine Virus Research 312

Science Daily: Pharmacology News

DECEMBER 19, 2024

Stitching together four molecules found in the standard flu vaccine ensures an immune response to all of them, scientists have shown.

Vaccine 259

Vaccine Immune Response 259

Science Daily: Pharmacology News

FEBRUARY 5, 2025

Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune response after initiation of a personalized cancer vaccine.

Vaccine 286

Vaccine Immune Response Clinical Trials Trials 286

Science Daily: Pharmacology News

AUGUST 31, 2023

A new study found that more than half of people who own dogs expressed some level of canine vaccine hesitancy -- i.e. skepticism about vaccinating their pets against rabies and other diseases.

Vaccine 256

Vaccine Disease 256

Science Daily: Pharmacology News

OCTOBER 30, 2023

A mechanism that led some patients to experience cases of deadly clotting following some types of Covid-19 vaccination has been identified in new research.

Vaccine 268

Vaccine Research 268

Science Daily: Pharmacology News

SEPTEMBER 7, 2023

By adding synergistic self-adjuvanting properties to Covid-19 RNA vaccines, researchers showed they could significantly boost the immune response generated in mice.

RNA 235

RNA Vaccine Engineering Immune Response 235

Science Daily: Pharmacology News

JUNE 14, 2023

Despite some of the most successful international vaccination campaigns in history, the poliovirus continues to circulate around the world, posing a threat of neurological damage and even paralysis to anyone who is not vaccinated.

Vaccine 231

Vaccine International 231

Science Daily: Pharmacology News

APRIL 4, 2025

Low vaccination rates for influenza viruses and the lack of an HSV vaccine underscore the need for a new approach to reduce viral transmission. Researchers have now used a clinical-grade antiviral chewing gum to substantially reduce viral loads of two herpes simplex viruses and two influenza A strains in experimental models.

Virus 346

Virus Vaccine Research 346

Science Daily: Pharmacology News

JANUARY 3, 2025

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria.

Research 326

Research Vaccine Treatment 326

Science Daily: Pharmacology News

MAY 1, 2024

An experimental influenza vaccine carrying more than 80,000 variations of hemagglutinin antigens caused the immune system of mice and ferrets to respond more strongly to less variable portions of the virus. This is a big step forward in efforts at the Duke Human Vaccine Institute to develop a universal, long-lasting flu shot.

Vaccine 288

Vaccine Virus 288

DrugBaron

JANUARY 2, 2021

Over the past week a furious debate has broken out over the merits of delaying the second dose of the approved COVID vaccines, to increase the number of people who can be given a single dose. The case against doing so is clear: the labels of the approved vaccines are unambiguous that two doses should be given within a certain time window.

Vaccine 100

Vaccine Science Trials Clinical Trials 100

Science Daily: Pharmacology News

MARCH 19, 2025

New imaging reveals a built-in safeguard that allows B cell populations to rapidly expand in germinal centers without introducing deleterious mutations.

Vaccine 220

Vaccine 220

PPD

JUNE 24, 2024

In the realm of vaccine development, mega trials — studies enrolling 5,000 subjects or more — have been instrumental in the fight against many pathogens, including influenza, rotavirus, malaria, RSV and most recently in the rapid development of vaccines against COVID-19.

Vaccine 97

Vaccine Trials Clinical Trials Laboratories 97

National Institute on Drug Abuse: Nora's Blog

FEBRUARY 1, 2024

50 years after founding, NIDA urges following science to move beyond stigma area Thu, 02/01/2024 - 11:20 Nora's Blog February 1, 2024 Image NIDA Image In 2024, NIDA celebrates its 50th anniversary. The knowledge generated by NIDA research has also led to a robust and rigorous science of drug use prevention.

Science 122

Science FDA Approval Treatment Research 122

keypoint

JULY 25, 2024

On September 10, 2024, Keystone Symposia will host a free ePanel event featuring the recipients of the Michelson Philanthropies & Science Prize for Immunology. The winner is awarded $30,000 and the publication of his or her essay in Science.

Science 70

Science Vaccine International Research 70

Drug Target Review

DECEMBER 9, 2024

Baker’s model could revolutionise drug development, synthetic biology, and nanotechnology, opening possibilities for new medical treatments, vaccines, nanomaterials, and sensors. The Rosetta algorithm has been incorporated into AI-powered tools like RoseTTAfold, which uses a three-track neural network to predict protein structures.

Engineering 105

Engineering International Drug Development Science 105

SCIENMAG: Medicine & Health

AUGUST 8, 2023

PHILADELPHIA – A new study finds that people are more likely to recommend that a pregnant family member or friend get vaccinated to protect the infant from RSV illness if they are shown a chart outlining the rigorous process a vaccine undergoes to be approved by the Food and Drug Administration (FDA).

Vaccine 88

Vaccine FDA Drugs Science 88

Eye on FDA

SEPTEMBER 10, 2020

Vaccines for COVID-19 are the focus of the moment – politically and scientifically speaking. Scientifically, there was the big news that a vaccine trial had experienced a serious adverse event bringing a pause to bear in its continuation, likely throwing further cold water on the political side of the equation.

Vaccine 82

Vaccine Research Government Science 82

SCIENMAG: Medicine & Health

AUGUST 10, 2023

Childhood vaccinations are a crucial component of preventative care, but vaccination rates remain below the World Health Organization’s goal of reaching 95% of children. URBANA, Ill. Madagascar is one of the poorest countries in the world and access to health care is limited for many people.

Vaccine 91

Vaccine Science 91

Science Daily: Pharmacology News

JANUARY 16, 2025

A study involving over 600 fully vaccinated children in South Africa found those who were undernourished had substantially lower levels of antibodies against measles. Amid a global surge in measles cases, new research suggests that undernutrition may be exacerbating outbreaks in areas suffering from food insecurity.

Research 188

Research Vaccine 188

keypoint

DECEMBER 4, 2023

In addition to covering emerging developments in vaccine science, design and technology, the Vaccinology During and After COVID-19 Keystone Symposium held in Atlanta on September 17-20, 2023, highlighted many aspects of health equity surrounding development and deployment of vaccines globally.

Vaccine 89

Vaccine Science 89

keypoint

FEBRUARY 17, 2023

On April 11, we celebrated the 2022 recipients of the Michelson Philanthropies & Science Prize for Immunology in this live ePanel event. This international prize focuses on transformative research in human immunology, with trans-disease applications to accelerate vaccine and immunotherapeutic discovery.

Science 52

Science Vaccine International Disease 52

PLOS: DNA Science

OCTOBER 24, 2024

Experts regularly held zooms with science journalists, providing technical updates that we used to inform our articles, blog posts, podcasts, and other means of communication. “Do Your Own Research” Fuels Science Illiteracy COVID reawakened the mantra DYOR: do your own research. Science is about data, not “content.”

Science 52

Science Research Vaccine Government 52

Drug Target Review

MARCH 26, 2024

DGG: At Osivax, we’re working on a new class of vaccines that target invariant parts of mutating viruses; this approach is disruptive and very different from conventional vaccines. DGG: Resilience: In science, we can’t predict and control everything. Sometimes science “speaks” and sometimes it doesn’t.

Vaccine 110

Vaccine Virus Immune Response Science 110

SCIENMAG: Medicine & Health

OCTOBER 2, 2023

The paper, “Understanding low bivalent COVID-19 booster uptake among US adults,” was published in the journal Vaccine. Credit: UArizona Health Sciences The paper, “Understanding low bivalent COVID-19 booster uptake among US adults,” was published in the journal Vaccine.

Vaccine 52

Vaccine Science 52

Broad Institute

SEPTEMBER 23, 2024

Protein boost The mRNA vaccines developed for COVID-19 only need to generate a modest amount of protein in order for the immune system to kick in and develop robust antibodies against infection. and Virginia Cabot Associate Professor of Chemistry at MIT. Funding This research was funded in part by the Searle Scholars Program, Thomas D.

RNA 134

RNA Vaccine Small Molecule Therapies 134

Drug Target Review

JANUARY 23, 2024

Vaccinations against tumour antigens that are shared between tumours, or tumour antigens that arise from mutations unique to individual tumours, represent promising strategies. We anticipate this area to grow, especially cancer vaccines, with important read-outs expected across various cancer types in 2024.

Treatment 122

Treatment Immune Response Vaccine Therapies 122

BMG Labtech

MARCH 11, 2024

Enzyme-Linked Immunosorbent Assays (ELISAs) are an essential technique in today’s laboratory with many applications in the life sciences. Many proven applications The use of ELISAs has flourished in the life sciences. ELISAs can also be used to measure the antibody responses elicited by vaccines.

Vaccine 98

Vaccine Molecular Biology Laboratories Virus 98

The Pharma Data

MAY 5, 2022

In animal studies that mimic human exposures, an investigational COVID vaccine designed to be taken orally not only protects the host, but also decreases the airborne spread of the virus to other close contacts. The findings are published today in the journal Science Translational Medicine. Langel, Ph.D., Langel, Ph.D.,

Vaccine 52

Vaccine Disease Virus Science 52

Fierce BioTech

AUGUST 15, 2023

HLTH 2023 – NEW Pharma & Life Sciences Insights Program Join industry leaders at HLTH! Learn how digital technology is accelerating translational research and paving the path towards personalized treatments and patient care. Register Now!

Science 52

Science Vaccine Treatment Marketing 52

Broad Institute

MARCH 22, 2024

McAlpine March 22, 2024 Credit: Catherine Boush, Broad Communications Related news New method tracks gene expression in single cells over space and time Messenger RNA (mRNA) made its big leap into the public limelight during the pandemic, thanks to its cornerstone role in several COVID-19 vaccines. and Virginia W. Cabot Professorship, E.

Engineering 140

Engineering Protein Production RNA Vaccine 140